Michael Gibertini, President Clinical Development at INC Research Holdings, Inc. (INCR), sold 9,000 shares at $40.45 ($365K) on 2016-02-01, disclosed to the SEC on 2016-02-02.
Open-market sale of $365k INCR by President Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.45 | 8,000 | $324K | 88.6% |
| 2 | $41.56 | 1,000 | $42K | 11.4% |
| Total | $40.57 avg | 9,000 | $365K | 100% |
| Filing → |
| INCR | SELL | 2016-03-02 | $359K | — | Filing → |
| INCR | SELL | 2016-01-06 | $421K | — | Filing → |
| INCR | SELL | 2015-12-03 | $419K | — | Filing → |